We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+5.3%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.53B
AUM Growth
+$159M
(+3%)
Cap. Flow
-$12.4M
Cap. Flow
% of AUM
-0.22%
Top 10 Holdings %
Top 10 Hldgs %
20.92%
Holding
797
New
64
Increased
251
Reduced
262
Closed
82
Avg Time Held
1.1
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ulta Beauty
ULTA
|
+$42M |
| 2 |
CF Industries
CF
|
+$41.4M |
| 3 |
BEAV
B/E Aerospace Inc
BEAV
|
+$36.2M |
| 4 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$33.3M |
| 5 |
Sunoco
SUN
|
+$29.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$55.7M |
| 2 |
ITC
ITC HOLDINGS CORP
ITC
|
+$38.9M |
| 3 |
AGN
Allergan Inc
AGN
|
+$38.3M |
| 4 |
Accenture
ACN
|
+$37.2M |
| 5 |
Tesla
TSLA
|
+$35.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.43% |
| 2 | Financials | 16.55% |
| 3 | Consumer Discretionary | 12.19% |
| 4 | Industrials | 12.01% |
| 5 | Technology | 10.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
MON
26
DELISTED
Monsanto Co
MON
| $67.7M | 1.23% |
601,779
-7,237
| -1% | -$860K |
2013 Q2
7 quarters
|
|
27
Microsoft
MSFT
$3.96T
| $67.2M | 1.22% |
1,653,261
-212,806
| -11% | -$9.26M |
2013 Q2
7 quarters
|
|
|
28
Sunoco
SUN
$14B
| $67.2M | 1.21% |
1,307,708
+578,149
| +79% | +$29.2M |
2013 Q4
5 quarters
|
|
29
Acadia Healthcare
ACHC
$2.95B
| $67.1M | 1.21% |
936,747
-12,658
| -1% | -$812K |
2013 Q2
7 quarters
|
|
30
Gartner
IT
$12.4B
| $65M | 1.18% |
775,508
-10,648
| -1% | -$879K |
2013 Q2
7 quarters
|
|
31
Microchip Technology
MCHP
$38.7B
| $64.3M | 1.16% |
2,630,896
+35,168
| +1% | +$848K |
2013 Q2
7 quarters
|
|
32
Whirlpool
WHR
$1.8B
| $64M | 1.16% |
316,962
+5,461
| +2% | +$1.11M |
2013 Q2
7 quarters
|
|
33
Home Depot
HD
$295B
| $63.9M | 1.16% |
562,091
+9,986
| +2% | +$1.1M |
2013 Q2
7 quarters
|
|
34
Amazon
AMZN
$2.74T
| $59.3M | 1.07% |
3,186,440
-37,340
| -1% | -$657K |
2013 Q2
7 quarters
|
|
35
Middleby
MIDD
$4.8B
| $54.5M | 0.99% |
530,469
-11,858
| -2% | -$1.2M |
2013 Q2
7 quarters
|
|
36
DELISTED
Stericycle Inc
SRCL
| $54.1M | 0.98% |
384,963
-4,933
| -1% | -$666K |
2013 Q2
7 quarters
|
|
37
Tyler Technologies
TYL
$14.3B
| $52.9M | 0.96% |
438,757
+85,876
| +24% | +$9.84M |
2013 Q2
7 quarters
|
|
38
AbbVie
ABBV
$501B
| $51.4M | 0.93% |
877,405
-338,828
| -28% | -$20.5M |
2013 Q2
7 quarters
|
|
39
Icon
ICLR
$13B
| $51.2M | 0.93% |
726,034
-6,214
| -0.8% | -$385K |
2013 Q2
7 quarters
|
|
40
Enterprise Products Partners
EPD
$77.3B
| $47.6M | 0.86% |
1,444,568
+95,900
| +7% | +$3.21M |
2013 Q2
7 quarters
|
|
41
Robert Half
RHI
$3.58B
| $47.4M | 0.86% |
782,844
-18,615
| -2% | -$1.12M |
2013 Q2
7 quarters
|
|
|
42
Ulta Beauty
ULTA
$25.3B
| $45.8M | 0.83% |
+303,437
| New | +$42M |
2015 Q1
0 quarters
|
|
43
Polaris
PII
$2.88B
| $44.2M | 0.8% |
313,602
-91,007
| -22% | -$13.4M |
2013 Q2
7 quarters
|
|
44
Brookfield
BN
$80.3B
| $44M | 0.8% |
3,506,936
+35,606
| +1% | +$441K |
2013 Q2
7 quarters
|
|
|
SCU
45
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $40.5M | 0.73% |
320,539
+9,137
| +3% | +$1.1M |
2014 Q2
3 quarters
|
|
|
46
CF Industries
CF
$18.1B
| $40.5M | 0.73% |
713,015
+694,175
| +3,685% | +$41.4M |
2013 Q2
7 quarters
|
|
47
Centene
CNC
$34.7B
| $39.5M | 0.71% |
1,118,068
-536
| -0% | -$16.1K |
2014 Q1
4 quarters
|
|
|
MHFI
48
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| $38.4M | 0.7% |
371,653
+136,167
| +58% | +$13.4M |
2013 Q4
5 quarters
|
|
49
Salesforce
CRM
$194B
| $38.2M | 0.69% |
572,355
-9,320
| -2% | -$578K |
2013 Q2
7 quarters
|
|
50
Ecolab
ECL
$80.7B
| $38.2M | 0.69% |
334,054
-8,999
| -3% | -$986K |
2013 Q2
7 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, Geneva Advisors held 797 positions worth $5.53B, up 3% from $5.37B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Geneva Advisors's Q1 2015 filing shows 64 new, 251 increased, 262 reduced and 82 closed positions. Its largest new stake was Ulta Beauty: 303,437 shares worth $45.8M. The largest sale was Johnson & Johnson, an estimated $55.7M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geneva Advisors's largest Q1 2015 buy was Ulta Beauty: 303,437 shares worth $45.8M.
- Geneva Advisors added most to CF Industries in Q1 2015, an estimated $41.4M increase.
- Geneva Advisors's biggest Q1 2015 reduction was Johnson & Johnson, cutting an estimated $55.7M.
- Geneva Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $38.3M.
- Geneva Advisors's ten largest holdings make up 21% of its $5.53B portfolio in Q1 2015.
- Geneva Advisors opened 64 new positions and closed 82 in Q1 2015.
- Geneva Advisors's portfolio value rose 3% quarter-over-quarter to $5.53B.
Based on Geneva Advisors's 13F filing for Q1 2015, filed 5 May 2015.